DEDICATED TO THE
FINEST EQUESTRIAN CARE
RenoVō® is an equine amniotic tissue allograft intended to supplement and protect tissues.

EQUINE AMNIOTIC TISSUE ALLOGRAFT
RenoVō® has been used in over 2000 horses to date and is enjoying increasing interest among veterinarians and owners as a superior alternative to autologous and other therapies.
LEARN MORETHE RENOVō® ADVANTAGE
• Amniotic tissue allograft
• Allogeneic
• Cryopreserved
• Versatile storage conditions
• Supplied in 1.5 cc, 3.0 cc, 5.0 cc volumes
• High concentrations of Interleukin-1 receptor antagonist protein
• High levels of growth factors/cytokines
• Consistent protein profile
• Aseptically manufactured and sterility tested
• Readily available as an off-the-shelf product
• Single administration
• Moderate cost
• No donor morbidity
IRAP I/II
• Whole blood preparation
• Autologous
• Moderate to High concentration of Interleukin-1 receptor antagonist protein
• Contains growth factors/cytokines
• Variable protein profile between patients
• Time lapse from harvest to utilization
• Inherent risk of contamination during preparation
• Single to multiple administrations
• Moderate cost
• No donor morbidity
PRP
• Whole blood preparation
• Autologous
• Low concentration of Interleukin-1 receptor antagonist protein
• Contains growth factors/cytokines
• Variable protein profile between patients
• Point of care deployment
• Inherent risk of contamination during preparation
• Single to multiple administration
• Low cost
• No donor morbidity
Stem Cells
• Cell-based product
• Autologous
• Allogeneic
• Time-lapse from harvest to utilization
• Expanded cells in culture with potential loss of purity and potency
• Contains low levels of growth factors/cytokines
• Inherent risk of contamination during preparation
• Single administration
• High Cost
• Donor morbidity
Hyaluronic Acid
• Synthetic
• Readily available as an off-the-shelf product
• Single to multiple administrations
• Low cost
• No donor morbidity